Elevated Serum α-Synuclein Autoantibodies in Patients with Parkinson’s Disease Relative to Alzheimer’s Disease and Controls
Early diagnosis of neurodegenerative diseases is of paramount importance for successful treatment. Lack of sensitive and early biomarkers for diagnosis of diseases like Parkinson’s disease (PD) is a handicapping problem for all movement disorders specialists. Using serum autoimmune antibodies (AIAs)...
Main Authors: | Ali Shalash, Mohamed Salama, Marianne Makar, Tamer Roushdy, Hanan Hany Elrassas, Wael Mohamed, Mahmoud El-Balkimy, Mohamed Abou Donia |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-12-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fneur.2017.00720/full |
Similar Items
-
Naturally occurring autoantibodies against α-synuclein rescues memory and motor deficits and attenuates α-synuclein pathology in mouse model of Parkinson's disease
by: Ya-ru Huang, et al.
Published: (2019-04-01) -
Tubulin and Tau: Possible targets for diagnosis of Parkinson's and Alzheimer's diseases.
by: Mohamed Salama, et al.
Published: (2018-01-01) -
Salivary alpha-synuclein (total and oligomeric form): potential biomarkers in Parkinson’s disease
by: Hala Shaheen, et al.
Published: (2020-02-01) -
Distinct Autoimmune Anti-α-Synuclein Antibody Patterns in Multiple System Atrophy and Parkinson’s Disease
by: Jonas Folke, et al.
Published: (2019-09-01) -
Autoimmune antibody decline in Parkinson’s disease and Multiple System Atrophy; a step towards immunotherapeutic strategies
by: Tomasz Brudek, et al.
Published: (2017-06-01)